Class I - Dangerous
Chemical contamination; presence of lead and lithium above specification
Acella Pharmaceuticals
Class I - Dangerous
Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.
Class I - Dangerous
Subpotent drug
Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.
Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.
Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.
Subpotent Drug
Subpotent Drug
Class I - Dangerous
Subpotent Drug
Class I - Dangerous
Subpotent Drug
Subpotent Drug
Class I - Dangerous
Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.
Class I - Dangerous
Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.
Class I - Dangerous
Superpotent Drug.
Class I - Dangerous
Superpotent Drug.
Class I - Dangerous
Superpotent Drug.